Added10-Q 2026-10-22 vs 10-K 2026-02-13
Item 2. Unregistered Sales of Equity Securities, Use of Proceeds and Issuer Purchases of Equity Securities
DOVDover Corporation
- Employees
- 24,000
- Headquarters
- Downers Grove, IL
- CEO
- Richard J. Tobin
- Next results
- around Jan 28, 2027
1 paragraph in Risk Factors of the 10-K filed Feb 13, 2026 with nothing like it in the 10-K filed Feb 14, 2025. Quoted exactly. Paragraphs that were only edited are under 10-K change.
Compared with the Risk Factors in the latest 10-K of the other 81 Industrials companies: a paragraph with at least half its words the same at another company is called similar, and the companies are listed under it. A paragraph most of them have is marked boilerplate. No line means no other company has one like it. This counts text; it does not say how serious a risk is.
changes relating to climate change related policies, they could lose customers to competitors. If our businesses do not compete effectively, we may experience lower revenue, operating profits and cash flows.
Read in the 10-K ↗
New in the latest 10-Q
9 paragraphs in the 10-Q filed Oct 22, 2026 with nothing like them in the 10-Q filed Jul 23, 2026 (at least half the words must differ; new numbers alone do not count). Quoted exactly, grouped by the item heading above them. This is text that changed, not a judgement of how serious it is.
Financial statements and notes
On August 12, 2026, the Company acquired 100 % of the equity interest in Cloeren Incorporated ("Cloeren"), a manufacturer of high-performance, custom-designed extrusion head systems for polymer and plastics applications for $ 39,246, net of cash acquired. The Cloeren business was acquired to complement existing operations and expand the Company's ability to serve customers with a broader, more complete solution across polymer processing applications within the Pumps & Process Solutions segment. The purchase accounting for Cloeren is preliminary.
Read in the 10-Q ↗
On August 18, 2026, the Company entered into a definitive agreement to acquire Leistung Engineering Pvt. Ltd., a specialized manufacturer of cryogenic and diaphragm valves, filtration systems, and related products, for total preliminary consideration of $ 40,000, subject to post-closing adjustments. The transaction is subject to satisfaction of customary closing conditions, including receipt of regulatory approvals, and is expected to close in the fourth quarter of 2026. This acquisition adds complementary offerings within the Clean Energy & Fueling segment.
Read in the 10-Q ↗
On October 9, 2026, the Company entered into a definitive agreement to sell an equity method investment. The transaction is subject to satisfaction of customary closing conditions, including receipt of regulatory approvals, and is expected to close in the fourth quarter of 2026. The Company expects to receive approximately $ 43,000 representing its proportionate share of the preliminary proceeds.
Read in the 10-Q ↗
Nine Months Ended September 30, 2026 Compared to the Nine Months Ended September 30, 2025
Read in the 10-Q ↗
Nine Months Ended September 30, 2026 Compared to the Nine Months Ended September 30, 2025
Read in the 10-Q ↗
Nine Months Ended September 30, 2026 Compared to the Nine Months Ended September 30, 2025
Read in the 10-Q ↗
Nine Months Ended September 30, 2026 Compared to the Nine Months Ended September 30, 2025
Read in the 10-Q ↗
Nine Months Ended September 30, 2026 Compared to the Nine Months Ended September 30, 2025
Read in the 10-Q ↗
On October 9, 2026, the Company entered into a definitive agreement to sell an equity method investment and expects to receive approximately $43.0 million, representing its proportionate share of the preliminary proceeds, subject to satisfaction of customary closing conditions, including receipt of regulatory approvals. See Note 20 - Subsequent Events in the condensed consolidated financial statements in Item 1 of this Form 10-Q for further details.
Read in the 10-Q ↗
The 10-Q's risk factors against the 10-K
Item 1A of the 10-Q filed Oct 22, 2026 against Item 1A of the 10-K filed Feb 13, 2026.
A 10-Q repeats only the risks that changed, so a 10-K paragraph that is missing from it is not counted as removed.
Added is a paragraph with nothing like it in the 10-K, Reworded a sentence that is in both with several words changed,
Quiet changes a sentence in both where one to four words changed and one is a hedge or a modal
(cut words struck through, new words highlighted and underlined).
Text on the page, not a score; each links to the filing at sec.gov.
What the 10-Q itself says about its risk factors:
Read in the 10-Q ↗
There have been no material changes from the risk factors previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2025.
Added10-Q 2026-10-22 vs 10-K 2026-02-13
c.The below table presents shares of Dover Stock that we acquired during the quarter
Added10-Q 2026-10-22 vs 10-K 2026-02-13
(1) In August 2023, the Company's Board of Directors approved a new standing share repurchase authorization whereby the Company may repurchase up to 20 million shares beginning on January 1, 2024 through December 31, 2026. The Company repurchased 1,684,185 shares under the August 2023 authorization during the three months ended September 30, 2026. As of September 30, 2026, the number of shares still available for repurchase under the current share repurchase authorization was 12,508,871.
Work on DOV in a spreadsheet:
Excel workbook (a sheet per section, ten years by column, charts, links to the filings) ·
CSV.
For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/DOV/export.csv") into a cell.